[Oral combination chemotherapy with capecitabine and cyclophosphamide in combination with endocrine therapy and anti-HER2 therapy for advanced and metastatic breast cancer].
Year: 2012
Type: article
Source: PubMed
Authors: Ryuji Okamura, Tatsushi Kato, Ritsuko Sata
Institution: Yamato Takada Municipal Hospital
Language: Japanese
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2398532062